These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23476677)

  • 1. Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential.
    Schnider JT; Weinstock M; Plock JA; Solari MG; Venkataramanan R; Zheng XX; Gorantla VS
    Clin Dev Immunol; 2013; 2013():495212. PubMed ID: 23476677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the early diagnoses and assessment of rejection in vascularized composite allotransplantation.
    Starzl R; Brandacher G; Lee WP; Carbonell J; Zhang W; Schnider J; Gorantla V; Schneeberger S; Zheng XX
    Clin Dev Immunol; 2013; 2013():402980. PubMed ID: 23431325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.
    Olariu R; Denoyelle J; Leclère FM; Dzhonova DV; Gajanayake T; Banz Y; Hayoz M; Constantinescu M; Rieben R; Vögelin E; Taddeo A
    J Surg Res; 2017 Oct; 218():49-57. PubMed ID: 28985877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Biodistribution of Tacrolimus after Topical Administration: Implications for Vascularized Composite Allotransplantation.
    Feturi FG; Schnider JT; Fanzio PM; Erbas VE; Oksuz S; Sahin H; Dong L; Unadkat JM; Spiess AM; Plock JA; Solari MG; Gorantla VS; Venkataramanan R
    Pharm Res; 2020 Oct; 37(11):222. PubMed ID: 33067715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
    Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local immunosuppression in vascularized composite allotransplantation (VCA): A systematic review.
    Safi AF; Kauke M; Nelms L; Palmer WJ; Tchiloemba B; Kollar B; Haug V; Pomahač B
    J Plast Reconstr Aesthet Surg; 2021 Feb; 74(2):327-335. PubMed ID: 33229219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates.
    Barth RN; Rodriguez ED; Mundinger GS; Nam AJ; Ha JS; Hui-Chou H; Jones LS; Panda A; Shipley ST; Drachenberg CB; Kukuruga D; Bartlett ST
    Am J Transplant; 2011 Jul; 11(7):1407-16. PubMed ID: 21668624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study.
    Fries CA; Lawson SD; Wang LC; Slaughter KV; Vemula PK; Dhayani A; Joshi N; Karp JM; Rickard RF; Gorantla VS; Davis MR
    PLoS One; 2019; 14(1):e0210914. PubMed ID: 30677062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity.
    Feturi FG; Unadkat JV; Zhang W; Hag ME; Wang Y; Komatsu C; Grybowski D; Zhang Z; Erbas V; Sahin H; Mcclaine S; Oksuz S; Plock J; Gorantla VS; Washington KM; Solari MG; Venkataramanan R; Spiess AM
    Pharm Res; 2022 Sep; 39(9):2179-2190. PubMed ID: 35915321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local Immunosuppression for Vascularized Composite Allografts: Application of Topical FK506-TyroSpheres in a Nonhuman Primate Model.
    Gama AR; Ng ZY; Shanmugarajah K; Mastroianni M; Randolph MA; Lellouch AG; Kohn J; Cetrulo CL
    J Burn Care Res; 2020 Nov; 41(6):1172-1178. PubMed ID: 32352521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
    Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
    Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily topical tacrolimus therapy prevents skin rejection in a rodent hind limb allograft model.
    Solari MG; Washington KM; Sacks JM; Hautz T; Unadkat JV; Horibe EK; Venkataramanan R; Larregina AT; Thomson AW; Lee WPA
    Plast Reconstr Surg; 2009 Feb; 123(2 Suppl):17S-25S. PubMed ID: 19182660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive effect of combination schedules of brequinar with leflunomide or tacrolimus on rat cardiac allotransplantation.
    Antoniou EA; Deroover A; Howie AJ; Chondros K; McMaster P; D'Silva M
    Microsurgery; 1999; 19(2):98-102. PubMed ID: 10188834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation.
    Jones NF; Hebebrand D; Buttemeyer R; Zhao M; Benhaim P; Rao U
    Plast Reconstr Surg; 2001 Mar; 107(3):777-84. PubMed ID: 11304605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Tacrolimus on Tissue-Specific, Protein-Level Inflammatory Networks in Vascularized Composite Allotransplantation.
    Aral AM; Zamora R; Barclay D; Yin J; El-Dehaibi F; Erbas VE; Dong L; Zhang Z; Sahin H; Gorantla VS; Vodovotz Y
    Front Immunol; 2021; 12():591154. PubMed ID: 34017323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulating adrenergic stress receptor signalling to enhance immunosuppression and prolong survival of vascularized composite tissue transplants.
    Kim M; Fisher DT; Bogner PN; Sharma U; Yu H; Skitzki JJ; Repasky EA
    Clin Transl Med; 2022 Aug; 12(8):e996. PubMed ID: 35994413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single Implantable FK506 Disk Prevents Rejection in Vascularized Composite Allotransplantation.
    Unadkat JV; Schnider JT; Feturi FG; Tsuji W; Bliley JM; Venkataramanan R; Solari MG; Marra KG; Gorantla VS; Spiess AM
    Plast Reconstr Surg; 2017 Feb; 139(2):403e-414e. PubMed ID: 28121868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
    Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
    Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute rejection in vascularized composite allotransplantation.
    Fischer S; Lian CG; Kueckelhaus M; Strom TB; Edelman ER; Clark RA; Murphy GF; Chandraker AK; Riella LV; Tullius SG; Pomahac B
    Curr Opin Organ Transplant; 2014 Dec; 19(6):531-44. PubMed ID: 25333831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local Injections of Tacrolimus-loaded Hydrogel Reduce Systemic Immunosuppression-related Toxicity in Vascularized Composite Allotransplantation.
    Dzhonova DV; Olariu R; Leckenby J; Banz Y; Prost JC; Dhayani A; Vemula PK; Voegelin E; Taddeo A; Rieben R
    Transplantation; 2018 Oct; 102(10):1684-1694. PubMed ID: 29794937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.